- Home
- IDYA vs FBK Comparison
IDYA vs FBK Comparison
Compare IDYA & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- FBK
- Stock Information
- Founded
- IDYA 2015
- FBK 1906
- Country
- IDYA United States
- FBK United States
- Employees
- IDYA N/A
- FBK N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- IDYA Health Care
- FBK Finance
- Exchange
- IDYA Nasdaq
- FBK Nasdaq
- Market Cap
- IDYA 2.0B
- FBK 2.4B
- IPO Year
- IDYA 2019
- FBK 2016
- Fundamental
- Price
- IDYA $21.85
- FBK $49.82
- Analyst Decision
- IDYA Strong Buy
- FBK Hold
- Analyst Count
- IDYA 13
- FBK 5
- Target Price
- IDYA $53.67
- FBK $50.20
- AVG Volume (30 Days)
- IDYA 972.2K
- FBK 133.3K
- Earning Date
- IDYA 02-13-2025
- FBK 04-14-2025
- Dividend Yield
- IDYA N/A
- FBK 1.52%
- EPS Growth
- IDYA N/A
- FBK N/A
- EPS
- IDYA N/A
- FBK 2.48
- Revenue
- IDYA $7,000,000.00
- FBK $443,569,000.00
- Revenue This Year
- IDYA $111.81
- FBK N/A
- Revenue Next Year
- IDYA $240.55
- FBK $8.78
- P/E Ratio
- IDYA N/A
- FBK $20.09
- Revenue Growth
- IDYA N/A
- FBK N/A
- 52 Week Low
- IDYA $19.96
- FBK $33.35
- 52 Week High
- IDYA $47.72
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- IDYA 43.52
- FBK 37.20
- Support Level
- IDYA $19.96
- FBK $51.54
- Resistance Level
- IDYA $21.65
- FBK $52.99
- Average True Range (ATR)
- IDYA 1.09
- FBK 1.22
- MACD
- IDYA -0.07
- FBK -0.28
- Stochastic Oscillator
- IDYA 33.57
- FBK 4.34
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.